Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia
Abstract Hypogammaglobulinemia is the most frequently observed immune defect in chronic lymphocytic leukemia (CLL). Although CLL patients usually have low serum levels of all isotypes (IgG, IgM and IgA), standard immunoglobulin (Ig) preparations for replacement therapy administrated to these patient...
Guardado en:
Autores principales: | Ana Colado, Esteban Enrique Elías, Valeria Judith Sarapura Martínez, Gregorio Cordini, Pablo Morande, Fernando Bezares, Mirta Giordano, Romina Gamberale, Mercedes Borge |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/228884abb3ea4cbb9bf9765125f589ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia
por: Crescenzio Francesco Minervini, et al.
Publicado: (2021) -
IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
por: S. A. Sel'kov, et al.
Publicado: (2014) -
Intravenous Immunoglobulin and its Complications
por: I Mohammadzadeh
Publicado: (2011) -
INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
por: V. A. Lazanovich, et al.
Publicado: (2014) -
Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
por: S Shahzad Mustafa, et al.
Publicado: (2021)